Guanglei Zhuang

5.9k total citations · 1 hit paper
75 papers, 4.2k citations indexed

About

Guanglei Zhuang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guanglei Zhuang has authored 75 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 23 papers in Oncology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guanglei Zhuang's work include Angiogenesis and VEGF in Cancer (10 papers), Axon Guidance and Neuronal Signaling (9 papers) and Cancer Genomics and Diagnostics (9 papers). Guanglei Zhuang is often cited by papers focused on Angiogenesis and VEGF in Cancer (10 papers), Axon Guidance and Neuronal Signaling (9 papers) and Cancer Genomics and Diagnostics (9 papers). Guanglei Zhuang collaborates with scholars based in China, United States and South Korea. Guanglei Zhuang's co-authors include Jin Chen, Napoleone Ferrara, Xiumin Wu, Jeff Settleman, Dana M. Brantley‐Sieders, Pengfei Ma, Ian Kasman, Pan Du, Ho-June Lee and Yi Cao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Guanglei Zhuang

71 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells

2014 438 citations Ho-June Lee, Guanglei Zhuang et al. Cancer Cell profile →

Peers

Countries citing papers authored by Guanglei Zhuang

Since Specialization

Citations

This map shows the geographic impact of Guanglei Zhuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanglei Zhuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanglei Zhuang more than expected).

Fields of papers citing papers by Guanglei Zhuang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guanglei Zhuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanglei Zhuang. The network helps show where Guanglei Zhuang may publish in the future.

Co-authorship network of co-authors of Guanglei Zhuang

This figure shows the co-authorship network connecting the top 25 collaborators of Guanglei Zhuang. A scholar is included among the top collaborators of Guanglei Zhuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guanglei Zhuang. Guanglei Zhuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ZBTB17/MIZ1 promotes peroxisome biogenesis by transcriptional regulation of PEX13 2025 ·The Journal of Cell Biology ·(unknown), Xi Chen, Hanlin Wang, Guanglei Zhuang, Zheng‐Jiang Zhu, Min Zhuang	0
2	Dynamic genome-wide mapping reveals how chromatin context shapes OGG1-mediated repair and related mutagenesis in human cells 2025 ·Nucleic Acids Research ·Jie Li, Lin Li, (unknown), (unknown), Yuxuan Li, (unknown), Jiao An, Guanglei Zhuang, Maoxiang Qian, Jinchuan Hu	0
3	ATF7IP/SETDB1-mediated epigenetic programming regulates thymic homing and T lymphopoiesis of hematopoietic progenitors during embryogenesis 2025 ·Nature Communications ·(unknown), Jiaxin Wu, (unknown), (unknown), (unknown), Xueli Hu, (unknown), Chen Wu, (unknown), Peng Xie, Guanglei Zhuang, Yuxuan Wu, Yiyue Zhang, Leonard I. Zon, Ping Zhu, Tao P. Zhong	1
4	Determining the status of tertiary lymphoid structures in invasive pulmonary adenocarcinoma based on chest CT radiomic features 2025 ·Insights into Imaging ·Ye Yu, Tianshu Yang, Pengfei Ma, Yan Zeng, Yongming Dai, (unknown), (unknown), Ying Zhang, Guanglei Zhuang, Yan Zhou, Huawei Wu	2
5	Synergistic induction of tertiary lymphoid structures by chemoimmunotherapy in bladder cancer 2024 ·British Journal of Cancer ·(unknown), Ruiyun Zhang, Di Jin, Tianxiang Zhang, (unknown), (unknown), (unknown), (unknown), Guanglei Zhuang, (unknown), Jinhai Fan	15
6	Selective Covalent Targeting of Pyruvate Kinase M2 Using Arsenous Warheads 2023 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Yan Cheng, Lin Cheng, Ying Qin, Zhenfeng Zhang, Aiwei Bi, Huaijiang Xiang, Xinheng He, Xiaoxu Tian, (unknown), Jian Zhang, Chao Peng, Zheng‐Jiang Zhu, Min Huang, Ying Li, Guanglei Zhuang, Li Tan	10
7	Development and external validation of nomograms for predicting individual survival in patients with ovarian clear cell carcinoma 2023 ·Cancer Medicine ·(unknown), Huaiwu Lu, Ying Zhou, Xiaoran Long, Qing Li, Guanglei Zhuang, Xia Yin, Wen Di	1
8	Divergent tumor and immune cell reprogramming underlying immunotherapy response and immune-related adverse events in lung squamous cell carcinoma 2023 ·Journal for ImmunoTherapy of Cancer ·Minjiang Chen, Pengfei Ma, Yongchang Zhang, Dong Wang, Zhuang Yu, Yujie Fu, Xiaojing Zhao, Mengzhao Wang, Guanglei Zhuang, Ying Jing	18
9	Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma 2022 ·Cancer Research ·(unknown), Ye Zhou, (unknown), Cheng Wang, (unknown), (unknown), (unknown), Ya‐Bin Tang, Qian Liang, (unknown), Lu Xu, Pengfei Ma, Guanglei Zhuang, Ling Bi, Ling Xu, Liang Zhu, Hongzhuan Chen, Ying Shen	42
10	USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade 2021 ·Nature Communications ·Zhaojuan Yang, Guiqin Xu, Boshi Wang, Yun Liu, Li Zhang, Tiantian Jing, Ming Tang, Xiaoli Xu, Kun Jiao, (unknown), Yujie Fu, (unknown), Xiaoren Zhang, Weilin Jin, Guanglei Zhuang, Xiaojing Zhao, Yongzhong Liu	35
11	Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2 2021 ·Cell chemical biology ·(unknown), Jianping Liu, Jiali Shen, Jialin Dai, Gang Xu, (unknown), Chao Han, Yaru Wang, Xiaolong Xu, Yilun Tong, Huaijiang Xiang, (unknown), Guanglei Zhuang, Junhao Hu, Zheng Zhang, Ying Li, Lifeng Pan, Li Tan	63
12	Molecular Targeted Therapies Elicit Concurrent Apoptotic and GSDME-Dependent Pyroptotic Tumor Cell Death 2018 ·Clinical Cancer Research ·Haijiao Lu, Shengzhe Zhang, Jie Wu, Minjiang Chen, Mei‐Chun Cai, Yujie Fu, Wenfeng Li, Jing Wang, Xiaojing Zhao, Zhuang Yu, Pengfei Ma, Guanglei Zhuang	204
13	Preclinical Efficacy and Molecular Mechanism of Targeting CDK7-Dependent Transcriptional Addiction in Ovarian Cancer 2017 ·Molecular Cancer Therapeutics ·Zhenfeng Zhang, Huixin Peng, Xiaojie Wang, Xia Yin, Pengfei Ma, Ying Jing, Mei‐Chun Cai, Jin Liu, Meiying Zhang, Shengzhe Zhang, Kaixuan Shi, Wei‐Qiang Gao, Wen Di, Guanglei Zhuang	58
14	Clonality, Heterogeneity, and Evolution of Synchronous Bilateral Ovarian Cancer 2017 ·Cancer Research ·Xia Yin, Ying Jing, Mei‐Chun Cai, Pengfei Ma, Yi Zhang, Cong Xu, Meiying Zhang, Wen Di, Guanglei Zhuang	23
15	Adaptive and Acquired Resistance to EGFR Inhibitors Converge on the MAPK Pathway 2016 ·Theranostics ·Pengfei Ma, Yujie Fu, Minjiang Chen, Ying Jing, Jie Wu, Ke Li, Ying Shen, Jianxin Gao, Mengzhao Wang, Xiaojing Zhao, Guanglei Zhuang	36
16	Metabolic and transcriptional profiling reveals pyruvate dehydrogenase kinase 4 as a mediator of epithelial-mesenchymal transition and drug resistance in tumor cells 2014 ·Cancer & Metabolism ·Yuting Sun, Anneleen Daemen, Georgia Hatzivassiliou, David Arnott, Catherine Wilson, Guanglei Zhuang, Min Gao, Peter Liu, Aaron Boudreau, Leisa Johnson, Jeff Settleman	98
17	Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells breakdown → 2014 ·Cancer Cell ·Ho-June Lee, Guanglei Zhuang, Yi Cao, Pan Du, Hyojin Kim, Jeff Settleman	438
18	Differential drug class‐specific metastatic effects following treatment with a panel of angiogenesis inhibitors 2012 ·The Journal of Pathology ·Alicia S. Chung, Marcin Kowanetz, Xiumin Wu, Guanglei Zhuang, Hai Ngu, David Finkle, László G. Kömüves, Franklin Peale, Napoleone Ferrara	71
19	Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy 2009 ·Cancer Research ·Guanglei Zhuang, Dana M. Brantley‐Sieders, David Vaught, Jian Yu, Lu Xie, Sam Wells, Dowdy Jackson, Rebecca S. Muraoka-Cook, Carlos L. Arteaga, Jin Chen	170
20	The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling 2008 ·Journal of Clinical Investigation ·Dana M. Brantley‐Sieders, Guanglei Zhuang, Donna J. Hicks, Wei Bin Fang, Yoonha Hwang, Justin Cates, Karen Coffman, Dowdy Jackson, Elizabeth Bruckheimer, Rebecca S. Muraoka-Cook, Jin Chen	223

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact